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ABSTRACT 
THE ROLE OF THE NOVEL LUPUS ANTIGEN, ACHERON, IN MODERATING 
LIFE AND DEATH DECISIONS 
May 2014 
ANKUR SHEEL B.S., UNIVERSITY OF MASSACHUSETTS AMHERST 
B.S., UNIVERSITY OF MASSACHUSETTS AMHERST 
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST 
Directed by: Professor Lawrence M. Schwartz 
 
Programmed cell death (PCD) is a major regulatory mechanism employed during 
development and homeostasis. The term PCD was coined to describe the death of the 
intersegmental muscles (ISMs) of moths at the end of metamorphosis. The timing of ISM 
death in the Tobacco Hawkmoth, Manduca sexta, is regulated by a fall in the titer of the 
steroid molting hormone 20-hydroxyecdysone (20E) late on day 17 of pupal-adult 
development. This triggers the release of the peptide hormone, Eclosion Hormone (EH), 
which mediates its effects via the secondary messenger cGMP. It has been previously 
demonstrated that ISM death requires de novo gene expression. One induced gene in the 
ISMs encodes the novel protein Acheron. However, Acheron’s role in PCD is unknown.  
Acheron is a novel member of the Lupus-Antigen family of RNA binding 
proteins. In humans, Acheron is expressed in many tissues including the myoepithelial 
cells in mammary ducts. Analysis of the mammary gland revealed that Acheron mRNA 
levels were elevated in some basal-like breast cancers in women. Ectopic expression of 
Acheron in human MDA-MB-231 breast cancer cells results in dramatic elevations in 
proliferation, angiogenesis and metastasis. Moreover, Acheron expressing MDA-MB-231 
cells in mouse xenographs resulted in tumors that were five times larger than control cell 
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tumors. These data suggests that Acheron enhances the growth of some human breast 
cancers. 
This thesis describes two primary studies. The first tested the hypothesis that 
Acheron functions as a survival protein for cells in vitro. MDA-MB-231 cells engineered 
to express Acheron were challenged with various death-inducing treatments, which act 
via different signaling pathways, to determine if Acheron expression confers survival. 
Acheron protects cells from apoptosis induced by nutrient withdrawal, proteosome 
inhibition, heat stress, mitochondrial toxins, inhibiting cellular respiration, DNA damage, 
and oxidative stress. The second study tested the hypothesis that Acheron is 
phosphorylated by a cGMP-dependent kinase in the ISMs when the cells initiate death 
following adult eclosion. Using a non-radioactive in-vitro kinase assay I observed that 
Acheron is phosphorylated via a cGMP-dependent kinase, presumed via kinase binding 
motif predictions to be Protein Kinase G. Furthermore I show that phosphorylation is 
coupled to Acheron degradation.   
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CHAPTER I 
 
INTRODUCTION 
 
A Brief History of Developmental Biology 
Scientists have sought answers to questions pertaining to embryonic development 
since times of antiquity. During the fourth century BC, Aristotle recorded his 
observations of embryos and stages during embryonic development to determine if 
development was the result of preformationism or epigensis (National Research Council, 
2000). As advances in technology gave rise to techniques such as microscopy, these 
observational studies became more refined. It was not until the late 19th century that the 
field of development really expanded. During 1880-1885, the first atlas of human 
embryos titled “Anatomie Menschlicher Embryonen” was published by Wilhelm His. 
This work was a collection of microscopic slides that was the first to map the 
development of the kidney, limbs, central nervous system, heart and eyes in vertebrate 
embryogenesis (National Research Council, 2000). Moreover it was during this time 
period that the first instance of cell death was recorded by Karl Vogt during his 
observations of amphibian metamorphosis (Vogt 1842).  
The late 19th century was an era during which experimental biology was on the 
rise and many systems were used to model development. In 1888 Wilhelm Roux 
conducted a hallmark study using a two-cell stage frog embryo. Roux killed one of the 
cells in this stage and observed that half an embryo developed. He concluded that cell 
fate was determined at the two cell and four cell stage (Roux, 1888). Seven years later 
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this was refuted by the work of Hans Driesch, who repeated Roux’s experiments in sea 
urchin embryos and showed that it was possible to remove portions from a developing 
embryo without affecting the resulting organism (Driesch, 1895).    
By the early 1900s techniques in experimental biology had advanced such that 
they involved tissue removal. One of the hallmark studies in this era was the 
transplantation experiment conducted by Hans Spemann and Hilde Mangold, in which 
they published their discovery of the effect of “organizers” in the African clawed toad 
Xenopus laevis (Spemann & Mangold, 1924).  They described the organizer as a cluster 
of cells that induces development of the central nervous system. Spemann won the 1935 
Nobel Prize in Physiology or Medicine for this very discovery.     
As techniques in cellular biology expanded, the next era in developmental biology 
focused on changes at the cellular level (Horder, 2010). Specifically, many studies sought 
to elucidate the role of the nucleus. Following his Nobel Prize, in 1938 Spemann 
published another landmark paper demonstrating that the nucleus of a cell remains 
totipotent after division (Spemann, 1938). By tying a piece of hair around a fertilized 
salamander egg, Spemann separated the nucleus from other cellular components and 
allowed the nuclear side of the constricted cell to divide until it reached the 16-cell stage. 
He then allowed the second half of the restricted cell to divide by removing the hair and 
allowing the nucleus to rejoin the other cellular components. The result of this 
experiment was the birth of a twin set of salamanders.  
This observation, along with the advances in nuclear transplantation techniques 
by Robert Briggs and Thomas J. King (Briggs and King, 1952), catalyzed the famous 
work of John Gurdon in 1962 in which he transplanted the nucleus from a fully 
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differentiated intestinal epithelium cell of feeding tadpoles into a enucleated Xenopus 
laevis egg to demonstrate that the nucleus contained the genetic information necessary to 
allow for full development (Gurdon, 1962). The advances by Spemann, Briggs and King 
and by Gurdon illustrated that developmental research began to focus more on 
mechanisms that regulated development. One such mechanisms was cell death.  
 
Cell Death 
Cell death was first observed over 150 years ago by Karl Vogt (Vogt, 1842) 
during his observations of amphibian metamorphosis, but it wasn’t until a review in 1951 
by Glucksman that cell death returned as a focus of developmental research. In his 
review, Glucksman “rediscovered” developmental cell death in embryological tissues by 
observing that the core of the notochord disappears (Glucksman, 1951).  
Glucksman’s review catalyzed many to pursue cell death, specifically Richard 
Lockshin and Caroll Williams. Lockshin and Williams examined the disappearance of the 
intersegmental muscles (ISMs), that was originally observed in 1935 (Kuwana, 1935) in 
the Pernyi silkmoth following adult eclosion (emergence) at the end of metamorphosis. 
The term Programmed Cell Death (PCD) was coined by Lockshin and Williams (1965) to 
describe the temporally predictable death of these muscles. Since Lockshin’s studies, the 
field of PCD has exploded: the Pubmed search engine lists more than 225,000 papers that 
use the term “PCD” as a descriptor. 
Today cell death is recognized to be a vital component of development and 
homeostasis in unicellular organisms (Shemarova, 2010), vertebrates and invertebrates 
(Ellis et al., 1991) and plants (Sergovia et al., 2003; Reape and McCabe, 2008). 
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Numerous phenomena during mammalian development have been attributed to PCD. For 
example, by using differential labelling of nuclei of human blastocysts in vitro Hardy et 
al (1989) observed that a vast number of cells undergo cell death during development. In 
vitro data from mouse embryos was used to show that cavitation of the proamniotic 
cavity depends upon cell death of the inner ectodermal cells (Coucouvanis et al., 1995). 
One classic example of cell death during development in humans is the disappearance of 
the interdigital cells during the formation of the fingers (Lindsten et al., 2000). In 
addition, cell death mechanisms are also involved in generating the four chambers of the 
heart (Abdelwahid et al., 2002).  
In 2002, H. Robert Horvitz received the Nobel Prize for Physiology or Medicine 
for elucidating the genetic pathway for the most common form of PCD, apoptosis, in the 
nematode Caenorhabditis elegans. Horvitz and colleagues identified mutations that 
specifically enhanced or prevented PCD and developed a pathway implicating specific 
genes in the process. In his work, Horvitz identified the first pro-apoptotic cell death 
genes, ced-3 and ced-4 (Yuan et al., 1990). Later, he identified ced-9, a homolog of Bcl-
2, as a gene that protects cells from death (Hengartner et al., 1994).  The conservation of 
this pathway is so extreme, that human Bcl-2 can substitute for ced-9 in worms and 
prevent cell death, despite more than 1.1 billion years of evolution (Vaux et al., 1992).  
 
Markers of Death 
Ultrastructural studies by Kerr, Wylie and Currie were the first to identify a 
common set of morphological changes that occurred in dying cells: nuclear and 
cytoplasmic condensation and fragmentation of the cell (Kerr et al., 1972), which they 
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termed “apoptosis”. These morphological changes warranted more mechanistic 
associated investigation. Consequently, today there are many molecular markers that are 
associated with cell death. 
One of the hallmarks of apoptotic cell death is the activation of endonucleases 
that cleave genomic DNA at the inter-nucleosomal linker which generates the classic 
“ladder” pattern on agarose gels therefore creating the classic ladder pattern that is seen 
during electrophoresis (Williams et al., 1974; Wyllie, 1980).   
In addition to nuclear changes, mitochondria undergo important changes during 
cell death. Cytochrome c, which normally resides inside the inner membrane of the 
mitochondria, is an important marker of death. In response to apoptotic stimuli, 
mitochondrial membrane permeability increases and cytochrome c is released into the 
cytosol where it binds Apaf-1 (Kroemer et al., 2007; Liu et al., 2004) and eventually 
leads to activation and proteolytic cleavage of pro-caspase 3 (Zou et al., 1997). Caspase-3 
then cleaves a variety of substrates within the cell that leads to the rapid demise of the 
cell (Porter et al., 1999). For example, caspase-dependent cleavage of flippase allows the 
phosphotidylserine to flip from the inner layer of the cell membrane to the outer layer, 
where it acts as a signal for phagocytosis of the dying cell by macrophages and other cells 
(Fadok et al., 1992).   
 
Manduca sexta 
One tool for gaining new insights into the control of PCD is to exploit an 
invertebrate model system.  In the Schwartz laboratory, we employ the tobacco 
 6 
 
hawkmoth Manduca sexta, a moth that is related to the silk moths studied by Lockshin. 
In fact, many labs use the two species interchangeably.  
Manduca require approximately 6 weeks to develop from an egg to an adult 
during which time they grow approximately 10,000 fold. They begin life as a spherical 
egg (diameter of 1.5 mm) deposited on a tobacco plant and hatch approximately 5 days 
after they are laid. The larval form lasts approximately 20 days during which the animal 
grows up to 70-80 mm in length. During the larval stage the animal spends the majority 
of its time and energetic resources feeding on tobacco or tomato leaves. Mature larvae 
wander away from the food source and burrow 10 to 15 cm into the ground where they 
pupate. Manduca pupa are large and oval shaped and measure an average of 45 to 60 mm 
in length. Under laboratory conditions, Manduca remain in their pupal state for 18 days 
and the adult moth emerges late on day 18. Adult moths live for approximately 10 days 
during which they allocate the majority of their energy and resources towards 
reproduction.  
 
PCD of Manduca ISMs 
The ISMs of Manduca are formed in the embryo and are the major abdominal 
muscles of the larva, pupa and pharate adult. They are divided into separate pairs of 
bilaterally symmetric bundles. The ISMS are composed of striated skeletal muscle fibers 
that are approximately 5 mm long and 1 mm diameter. During the larval stage, Manduca 
use these muscles for locomotion whereas the pupa uses them for abdominal movement 
during the eclosion behavior of the adult moth.  The ISMs represent the major amino acid 
stores required by the adult which are liberated when the cells undergo PCD (Schwartz, 
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2008; Figure 1.1).  In contrast to many experimental models of cell death that employ 
chemical or physical insults to initiate cell death, the loss of the ISM is a normal 
developmentally controlled process which offers a physiological means to the 
endogenous mechanisms that regulate PCD.    
Three days prior to eclosion, these muscle cells undergo normal hormonally 
controlled atrophy during which the cells lose 40% of their muscle mass and 15-20% of 
their volume (Schwartz and Truman, 1983). During this phase, there is no change in 
resting potential or force per cross-sectional area (Schwartz and Ruff, 2002). However, 
there is an increase in polyubiquitin mRNA expression and ubiquitin dependent 
proteolysis which presumably facilitates protein turnover (Schwartz et al., 1990; Haas et 
al., 1995).  
ISM death occurs coincident with adult eclosion and is marked by the rapid loss 
of mass (~ 4% per hour) and the resting potential (~ 2.5 mV per hour) (Schwartz and 
Ruff, 2002). By 30 hrs post-eclosion, almost all the muscle mass is lost and all that 
remains are whirls of connective tissue (Beaulaton and Lockshin, 1977). Muscles at day 
15, day 18 and 13 hours post-eclosion are depicted in Figure 1.2.  
Although these cells undergo PCD, they do not exhibit the classical signs of 
apoptosis, as there is no membrane blebbing, DNA fragmentation or chromatin 
condensation (Schwartz et al., 1993).  Instead, these cells die via autophagy. They exhibit 
membrane wrinkling, pyknosis and the retention of high molecular weight genomic 
DNA/ 
The trigger for ISM PCD in the adult is a fall in the steroid molting hormone 20-
hydroxyecdysone (20E) late on day 17 of the pupal stage (Schwartz and Truman, 1983). 
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The decline in 20E cause release of the peptide hormone Eclosion Hormone (EH) which 
acts as the proximal trigger for death. Addition of exogenous 20E during the time of 
eclosion blocks ISM PCD (Schwartz and Truman, 1984).  
In 1969 Lockshin demonstrated that ISM PCD in silkmoths could be blocked by 
inhibitors of RNA or protein synthesis (Lockshin, 1969) suggesting that death requires de 
novo gene expression. The Schwartz lab demonstrated that this was true and using the 
Manduca ISM model, they were the first group to clone death associated genes from any 
system (Schwartz et al., 1990a). Some of these genes encoded previously characterized 
proteins, including: polyubiquitin (Schwartz et al., 1990b); 20S and 26S proteasome 
subunits (Jones et al., 1995; Sun et al., 1997), and apolipophorin III (Sun et al., 1995).  
Others encoded novel proteins whose role in death and development was poorly 
understood, such as: SCLP (Small Cytoplasmic Leucine Rich Repeat Protein) (Kuelzer et 
al., 1999), DALP (Death Associated LIM-Only Protein) (Hu et al., 1999) and Acheron 
(Valavanis et al., 2007). 
    
Acheron 
 One of the novel genes that emerged from this screen encodes the protein 
Acheron, a 55 kDa protein that is a member of the Lupus Antigen (LA) family of RNA 
binding proteins (Valavanis et al., 2007). Northern blot analysis of Acheron mRNA 
expression in the ISMs during various stages of pupal/adult development in Manduca 
demonstrated that Acheron is expressed on day 18 of pupal development when the 
muscles become committed to die. qPCR data shows an approximately 980 fold 
induction of Acheron mRNA on day 18 of pupal development (Oppenheimer and 
 9 
 
Schwartz, unpublished). When animals are injected with the insect molting hormone 20-
hydroxyecdysone on the day preceding adult eclosion (day 17 of pupal-adult 
development), both ISM death and the expression of Acheron are delayed (Valavanis et 
al., 2007).  
Immunohistochemical analysis of the ISMs demonstrated that Acheron localizes 
to the presumptive M band in the muscles, suggesting that it is not freely dispersed within 
the myoplasm.  In agreement with this hypothesis, preliminary studies have shown that 
Acheron is not soluble in low salt extraction buffer and instead pellets with the contractile 
apparatus (Sheel, unpublished). 
In addition to expression in the ISMs of Manduca, Acheron is also expressed in the 
fruit fly Drosophila melanogaster. Microarray analysis during development in the fruit 
fly Drosophila melanogaster has demonstrated that Acheron expression increases 
dramatically just prior to adult eclosion, consistent with its expression in Manduca 
(http://flybase.org/reports/FBgn0033936.html).  Additional studies have demonstrated 
that Acheron is preferentially expressed in pharate adult fly heads (unpublished).  We are 
yet to resolve if Acheron is expressed in the brain or the eclosion associated ptilinal 
muscles (Laing, 1935). 
Acheron is well conserved across phylogeny and shares high sequence identity 
between insects and mammals, especially in certain domains (Valavanis et al., 2007).  In 
addition to an RNA binding motif, it also contains functional nuclear localization (NLS) 
and nuclear export signals (NES) (Shao et al., 2012).  Acheron binds to several proteins, 
including CASK (Weng et al., 2009) and the ubiquitin E3 ligase Ariadne-1 (Wang et al., 
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2003). Acheron also binds to the 5’ untranslated region of the collagen I mRNA and 
regulates both its subcellular localization and translatability (Cai et al., 2010). 
In summary, several lines of evidence suggest that Acheron is a phylogenetically 
conserved protein that may play key roles in normal development and pathogenesis.  The 
mechanisms by which Acheron mediates these effects have not been defined. The 
purpose of this thesis is to elucidate the role Acheron plays in programmed cell death in a 
mammalian model and to use this information to determine the role of Acheron during 
PCD of the ISMs.  
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Figure 1.1: ISM morphology in adult moths.  
Morphology of the ISMs of a newly eclosed adult (a) and a 30 hour old adult (b) via light 
microscopy.  Solid headed arrows show the muscles in panel A, whereas 30 hours later 
these muscles have disappeared. Scale bar is approximately 5 mm. Adapted from 
Schwartz (2008).  
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Figure 1.2 ISM morphology during pupal development  
ISM morphology determined via light microscopy during pupal development on Day 15, 
Day 18 and 13 hours post eclosion. Prior to day 18, there is a slight decrease in muscle 
mass with very little change in cell number, however 13 hours after eclosion there is a 
dramatic decrease in cell muscle mass.  
 
  
Day 15     Day 18  13 hrs PE 
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CHAPTER II 
 
THE ROLE OF ACHERON IN DETERMINING CELL SURVIVAL 
 
Introduction 
The sudden and dramatic appearance of Acheron during day 18 of Manduca 
pupal-adult development is intriguing. Specifically, why is the gene expressed when the 
ISMs become committed to die at this stage? Perhaps Acheron is sensitizing the ISMSs 
for death.  
Several studies have attempted to elucidate the role of Acheron in other 
invertebrate and vertebrate systems. One of the first studies investigating the function of 
this protein demonstrated that Acheron played an essential role during differentiation in 
myoblasts (Wang et al., 2009). Ectopic expression of Acheron in the mouse muscle 
satellite cell line C2C12 resulted forced cells to either differentiate or die.  It also drove the 
expression of the myogenic regulatory factor, MyoD. Moreover upon differentiation from 
myoblasts to multinucleated myotubes, Acheron expressing C2C12 cells formed larger 
myotubes than did vector control cells. Taken together, the data suggested that Acheron 
plays a role in driving muscle differentiation. In the same study, this hypothesis was 
tested in vivo using zebrafish embryos. A reduction in Acheron expression, via antisense 
morpholinos, led to a significant reduction in muscle fiber formation during 
embryogenesis, while ectopic Acheron expression enhanced muscle fiber formation 
(Wang et al., 2009).  
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During myogenesis, differentiation cues are provided by interactions between 
neighboring cells and the extracellular matrix. This interaction is mediated by 
transmembrane proteins known as integrins (Boettiger et al., 1995). Studies in C2C12 cells 
have explored the role of Acheron during the integrin-extracellular matrix interactions 
required during myogenesis (Glenn et al., 2010). Control and Acheron-expressing 
myoblasts each expressed the fibronectin receptor, composed of integrin subunits α5 and 
β1, and the laminin receptor upon differentiation, composed of integrin subunits α7 and 
β1.  Inhibiting Acheron expression using antisense RNA or a dominant negative form of 
the Acheron protein blocked expression of the laminin receptor. However, there was no 
change in expression of the fibronectin receptor. Taken together the data suggested that 
during differentiation Acheron may play a role in regulating cell adhesion and dynamics 
(Glenn et al., 2010).  
In a more recent study, the Schwartz laboratory demonstrated that Acheron is 
expressed in several human tissues, including certain neurons, cardiac muscle, kidney, 
skeletal muscle and mammary glands, specifically the myoepithilial cells. Relative to 
normal mammary tissue in women, Acheron expression is elevated in some basal- like 
breast cancers and suppressed in some non basal-like breast cancers (Shao et al., 2012).  
MDA- MB-231 human breast cancer cells that were engineered to express ectopic 
Acheron became more motile and expressed higher levels of VEGF  (vascular endothelial 
growth factor) and MMP-9 (Matrix metallopeptidase 9), two proteins associated with 
metastasis. Consistent with these in vitro data, transplantation of Acheron-engineered 
MDA-MB-231 human breast cancer cells into athymic mouse xenographs resulted in 
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enhanced angiogenesis and tumors that were five times larger than those obtained with 
vector control cells (Shao et al., 2012).  
Previous studies of the Acheron in mammalian models indicate that Acheron 
plays a role in differentiation and cell survival. The study by Shao et al. (2012), suggested 
that Acheron enhances tumor growth. To test the hypothesis that Acheron enhances 
tumor growth by functioning as a survival factor that protects cells from apoptosis, I 
treated the Acheron expressing MDA-MD-231 cells, used by Shao et al., (2012), with 
various toxic insults (Table 2.1). To mimic nutrient deprivation, I deprived the cells of 
serum supplemented media. To induce proteosome inhibition, I treated the cells with 
MG132. To induce oxidative stress I treated the cells with H2O2. To mimic heat stress, I 
cultured the cells at 44oC for 20 minutes. To disrupt mitochondrial function, I treated 
cells with Rotenone. To induce DNA damage, I treated the cells with the anti-cancer drug 
camptothecin. In addition, I also disrupted cellular respiration by inhibiting oxidative 
phosphorylation via carbonyl cyanide-3-chlorophenyl hydrazine (CCCP), a drug that 
inactivates cellular respiration by interfering with ATP synthesis via uncoupling the 
proton gradient that exists in the inner mitochondrial membrane. To determine if Acheron 
was indeed protecting the cells from the above mentioned insults, survival was 
determined using the XTT (2,3-Bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-
carboxanilide inner salt) cell viability assay.   
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Materials and Methods 
 
Cell Culture 
MDA-MB-231 cells expressing ectopic Acheron have been described previously 
(Shao et al., 2012). Briefly, the human Acheron coding sequence was subcloned into the 
pCMV-neo retroviral vector and MDA-MB-231 cells were transfected using Fugene 6 
(Roche, Indianapolis, IN). In order to generate a stable cell line, cells were selected with 
800 µg/mL G418 48 hours after transfection for a total of 2 weeks. Cells were cultured at 
5% CO2 and 37°C in Dulbecco’s modified Eagle medium (DMEM) containing 10% Fetal 
Bovine Serum (FBS) and penicillin/streptomycin. 
 
Western Blot 
Wildtype (WT), pCMV-Neo and pCMV-neo-Acheron cells were lysed in Lamelli 
buffer and centrifuged at 10,000xg at 4oC for 8 minutes. The resulting supernatant were 
boiled for 5 minutes and centrifuged for 1 min at 14,000xg at room temperature. 10 µg of 
protein was loaded on a 12% SDS-PAGE (Bio-Rad) and was electrophoresed for 1 hour 
at 150 volts at room temperature. Proteins were transferred to a PVDF membrane 
(Millipore). Membrane was blocked in 5% nonfat dry milk in PBST and incubated with a 
rabbit anti-Human Acheron antibody (1:100, Schwartz Laboratory). HRP labeled goat 
anti-rabbit antisera (Bio-Rad, 1:3000) and an ECL kit (VWR) were used for detection.    
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Cytotoxicity Assays 
Cells were washed twice with warm phosphate buffered saline (PBS) and 1x105 
cells were plated in a volume of 100µL per well in a Costar 96 well flat bottom plate 
(Corning Life Sciences). Cells were allowed to adhere overnight and were then 
challenged with various noxious treatments that would normally induce cell death. To 
induce oxidative stress using hydrogen peroxide (H2O2), cells were grown in DMEM 
lacking sodium pyruvate. For serum withdrawal, cells were incubated with DMEM 
lacking FBS for the times indicated.  
  Cells were incubated with noxious treatments for 24 hours except in the case of 
serum withdrawal, where cells were deprived of serum supplemented media for 6, 24 and 
48 hours. MG132 (Sigma) was used at 0.25 µM, 0.5 µM, 1 µM and 2 µM.  H2O2 (30%, 
Fisher) was used at 2 µM, 4 µM, 6 µM and 8 µM. For heat induced death, cells were 
cultured at 44oC for 20 minutes followed by 24 hour recovery.  Rotenone (Sigma) was 
used at 0.25 µM, 1 µM, 2.5 µM and 5 µM. Camptothecin (Sigma) was used at 100 nM, 
200 nM, 300 nM and 400 nM. Carbonyl cyanide-3-chlorophenyl hydrazone (Sigma) was 
used at 100 µM, 250 µM, 500 µM and 1000 µM.  
 Cell viability in the presence of noxious treatment was determined using XTT 
(2,3-Bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide inner salt) 
(Sigma) assay. Briefly, cells were cultured in the presence of the noxious agent for the 
indicated times and then centrifuged for 3 minutes at 800rpm at 37oC. After 
centrifugation, the media was removed and cells were resuspended in fresh growth media 
containing XTT at a final concentration of 0.5mg/mL. To allow for the reduction of the 
tetrazolium ring of XTT, cells were incubated at 5% CO2 and 37oC for 2 hours. 
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Absorbance values were determined at 490nM via the Flurostar Optima Plate reader. Cell 
survival was determined by dividing the absorbance of the treated sample by the 
absorbance of the sample treated with the appropriate vehicle control multiplied by 100 
for a percentage value. Each plate had 8 replicates and each experiment was repeated at 
least two times.  
 
Statistics 
Student’s two-tailed T tests were conducted using Microsoft Excel. Statistical 
significance is denoted by asterisks (* indicates p<0.05, ** indicates p<0.01, *** 
indicates p <0.005).   
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Results  
 Western blot analysis of lysate from WT, pCMV-neo empty vector and pCMV-
neo-Acheron transfected MDA-MB-231 cells shows a strong band at 55kDa present in 
only in the Acheron construct (Figure 2.1). 
 To test the hypothesis that ectopic expression of Acheron protected cells from 
toxicity induced by nutrient starvation, I cultured cells in serum free media (Figure 2.2). 
Acheron expressing cells deprived of serum for 6, 24 and 48 hours had an average 
survival of 89.16% ± 6.59%, 88.96% ± 4.54% and 58.91% ± 2.54% respectively 
compared to cells not deprived of serum. Vector control cells deprived of serum for 6, 24 
and 48 hours had an average survival of 91.03% ± 5.19%, 52.99% ± 2.99%, and 45.82% 
± 3.55% respectively. Acheron conferred protection to cells that had been deprived of 
nutrients for 24 hours (p<0.005) and 48 hours (p<0.005).  
 Next, Acheron expressing and vector control cells were incubated for 24 hours in 
the presence of the proteosome inhibitor, MG132 at concentrations of 0.25 µM, 0.5 µM, 
1.0 µM, and 2.0 µM (Figure 2.3). Ectopic expression of Acheron protected cells from 
toxicity induced by proteosome inhibition. Acheron expressing cells had average 
survivals of 97.45% ± 3.69%, 89.75% ± 7.39%, 76.82% ± 6.81%, and 63.07% ± 7.31% 
when exposed to 0.25 µM, 0.5 µM, 1.0 µM, and 2.0 µM MG132 respectively. Vector 
control cells treated with 0.25 µM, 0.5 µM, 1.0 µM, and 2.0 µM MG132 had average 
survivals of 66.37% ± 4.74%, 50.07% ± 3.92%, 39.53% ± 3.87% and 26.04% ± 3.28% 
respectively. Acheron conferred protection to cells treated with 0.25 µM MG132 
((p<0.005), 0.5 µM MG132 (p<0.005), 1.0 µM MG132 (p<0.005), and 2.0 µM MG132 
(p<0.005).  
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 Next, oxidative stress was induced by treatment with H2O2 (Figure 2.4). Acheron 
expressing cells treated with 2 mM, 4 mM, 6 mM and 8 mM H2O2 had average survivals 
of 64.05% ± 3.26%, 39.69% ± 3.24%, 35.42% ± 2.54% and 33.57% ± 2.96% respectively 
whereas vector control cells had average survivals of 94.46% ± 7.41%, 65.69% ± 7.77%, 
63.94% ± 6.17%, 49.24% ± 4.82%. Ectopic expression of Acheron did not protect cells 
from toxicity induced by oxidative stress. 
 Heat stress was tested next (Figure 2.5). Cells, normally cultured at 37oC, were 
placed at 44oC for 20 minutes and then allowed to recover for 24 hours. Cells that 
ectopically expressed Acheron had an average survival of 70.99% ± 3.44% compared to 
unstressed Acheron expressing cells, whereas vector control cells had an average survival 
of only 58.11% ± 3.28% compared to unstressed vector control cells. Overall, Acheron 
conferred protection against heat stress (p<0.005). 
 To determine if Acheron protected against mitochondrial toxins, cells were 
treated with rotenone (Figure 2.6). Acheron expressing cells treated with 0.25 µM, 1.0 
µM, 2.5 µM and 5 µM Rotenone had average survivals of 80.58% ± 6.18%, 71.04% ± 
5.49%, 23.31% ± 5.82% and 6.78% ± 2.14% respectively compared to untreated Acheron 
expressing cells, whereas vector control cells had average survivals of 68.93% ± 6.07%, 
47.87% ± 6.67%, 10.08% ± 2.52% and 2.66% ± 0.74% respectively compared to 
untreated vector control cells. Acheron conferred protection for cells exposed to rotenone 
concentrations of 1.0 µM (p<0.05) and 2.5 µM (p<0.005). 
 Next, cells were treated with the topoisomerase I inhibitor camptothecin, which is 
used clinically as an anti-cancer therapeutic (Figure 2.7). Acheron expressing cells 
treated with 100 nM, 200 nM, 300 nM and 400 nM camptothecin had average survivals 
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of 100.01% ± 1.95%, 97.51% ± 3.59%, 79.01% ± 4.24% and 48.49% ± 5.05% 
respectively compared to untreated Acheron expressing cells, whereas vector control 
cells had average survivals of 80.33% ± 3.22%, 57.79% ± 7.91%, 53.75% ± 7.15% and 
35.59% ± 8.52% respectively compared to untreated vector control cells. Acheron 
conferred protection when exposed to camptothecin concentrations of 100 nM (p<0.005) 
and 200 nM (p<0.005). 
 Finally, cells were treated with carbonyl cyanide-3-chlorophenyl hydrazone in 
order to inhibit cellular respiration by blocking oxidative phosphorylation (Figure 2.8). 
Acheron expressing cells treated with 100 µM, 250 µM, 500 µM and 1000 µM carbonyl 
cyanide-3-chlorophenyl hydrazone had average survivals of 91.19% ± 3.85%, 72.33% ± 
8.14%, 66.87% ± 6.31% and 23.33% ± 1.64% respectively compared to untreated 
Acheron expressing cells, whereas vector control cells had average survivals of 69.74% ± 
1.51%, 49.47% ± 5.64%, 36.98% ± 3.55% and 21.6% ± 2.71% respectively compared to 
untreated vector control cells. Acheron conferred protection when exposed to carbonyl 
cyanide-3-chlorophenyl hydrazone concentrations of 100 µM (p<0.005), 250 µM 
(p<0.05), and 500 µM (p<0.005).   
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Discussion 
The purpose of this study was to test the hypothesis that Acheron functions, in 
part, as a survival factor that can protect cells from a variety of insults.  I utilized the 
human breast cancer cell line MDA-MB-231 that had been engineered to ectopically 
express Acheron.  Both vector control and Acheron engineered cells were then 
challenged with stressors that act on multiple pathways with cells and determine is the 
cells could survive these insults.  
The first insult I employed was nutrient withdrawal via serum starvation. In 
MDA-MB-231 cells, the absence of nutrients due to serum starvation triggers cell cycle 
arrest and death through a p53 independent mechanism (Jang et al., 2000). Ectopic 
expression of Acheron protected cells from death after they were serum deprived for 24 
hours and 48 hours (Figure 2.2).  
The next class of toxins induced involved the buildup of misfolded and unfolded 
proteins. MG132 is toxic to cells because it binds to the N-terminal threonine residue of 
the β1 subunit of the 26S proteosome and blocks proteolysis (Myung et al., 2001). This 
results in a buildup of toxic levels of unfolded and misfolded proteins in the cell 
(Sherman and Goldberg, 2011). Of all the toxic stimuli tested in this study, ectopic 
expression of Acheron conferred the greatest degree of protection against MG132 
toxicity (Figure 2.3). In line with toxicity due to unfolded and misfolded proteins, the 
cells were also subjected to heat stress since elevating the temperature increases in the 
amount of misfolded and unfolded proteins in cancer cells (Jolly and Morimoto, 2000). 
Similar to MG132, ectopic expression of Acheron protected cells against toxicity due to 
heat stress (Figure 2.5). Taken together, the data from Figure 2.3 and Figure 2.5 suggests 
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that Acheron protects cells that are challenged with stress associated with misfolded and 
unfolded proteins. 
Many cells are subjected to oxidative stress due to transient increases in levels of 
reactive oxygen species (ROS).  Oxidative stress can be caused by a variety of 
endogenous and exogenous factors such as cellular senescence (Hagen et al., 1997), 
changes in levels of certain growth factors (Yu et al., 2006), and environmental factors 
such as UV radiation (Zhang et al., 1997). In order to determine if Acheron protects cells 
from ROS damage, I treated cells with H2O2. Acheron did not confer any protection 
against H2O2 treatment- in fact Acheron expression sensitized the cells to death as 
survival in control cells was significantly greater (Figure 2.4).   
The fact that Acheron sensitized cells to hydrogen peroxide induced toxicity 
warranted further investigation. Hydrogen peroxide can induce cell death via two 
different mechanisms: apoptosis (Cerella et al., 2009) and necrosis (Miyoshi et al., 2006). 
The process of death induced during these two pathways are drastically different. 
Structurally, cells undergoing necrosis lose cell membrane integrity, swell and ultimately 
rupture thereby releasing their cellular contents whereas cells undergoing apoptosis 
maintain membrane integrity, shrink and generally do not rupture. Moreover at the 
nuclear level, cells undergoing necrosis have random degradation of DNA whereas cells 
undergoing apoptosis undergo chromatin condensation and non-random fragmentation of 
DNA.  
Studies in human T-lymphoma Jurkat cells have shown that the mechanism of 
hydrogen peroxide induced death (apoptosis or necrosis) is dependent on concentration 
and time of exposure (Saito et al., 2006). Furthermore, studies treat MDA-MB-231 with 
 24 
 
3mM hydrogen peroxide as a positive control for necrosis (Galluzzi et al., 2012). Given 
the concentration of hydrogen peroxide used in this study, the data from Figure 2.4 
indicated that Acheron does not protect cells from necrosis triggered cell death. Perhaps 
Acheron mediates its necrosis effect through increased integrin expression, as necrosis is 
often observed with increased expression of α and β integrins (Bachmann et al., 2008). 
However, the question if Acheron protected against ROS induced apoptosis remained.      
Given that cell death was not induced in these cells unless the concentration of 
hydrogen peroxide was greater than 2mM for 24 hours, the data from Figure 2.4 suggest 
that ROS-induced apoptosis in MDA-MB-231 cells could not be achieved via hydrogen 
peroxide. Therefore toxicity due to rotenone was tested. Rotenone inhibits transfer of 
electrons from the iron-sulfur centers in the mitochondrial respiratory chain complex I to 
ubiquinone, which leads to elevated ROS production and cell death via apoptosis (Li et 
al., 2003). Ectopic Acheron expression did protect cells from rotenone toxicity (Figure 
2.6).  
In order to determine if Acheron mediates its effect with toxicities associated with 
mitochondria, cells were exposed to carbonyl cyanide-3-chlorophenyl hydrazine 
(CCCH). CCCH is an inhibitor of cellular metabolism as it interferes with oxidative 
phosphorylation during the electron transport chain by inhibiting cytochrome c oxidase 
(Tsyrlov et al., 1976). Acheron conferred protection against CCCH (Figure 2.8) 
indicating that it protected against mitochondrial associated toxicities.   
Finally, given that Acheron has a functional NLS and NES and the DNA binding 
winged helix-turn-helix domain (Brennan et al., 1989), I tested the hypothesis that 
Acheron protected against DNA damage by treating cells with camptothecin. 
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Camptothecin induces DNA damage by blocking the re-ligation step of the cleavage 
reaction of topoisomerase I during S-phase of the cell cycle (Liu et al., 2000). Indeed 
Acheron protected against toxicity due to camptothecin (Figure 2.7). One interpretation 
of this data is that Acheron may translocate into the nucleus and possibly utilize its 
winged helix-turn-helix domain in order to bind DNA thereby shielding it from the 
fragmentation that is typically observed during. However, this may not be the case since 
ISM death is not associated with fragmentation of DNA (Schwartz et al., 1993).  
Basal-like breast cancers are more aggressive and are typically associated with 
poor prognosis compared to non basal-like breast cancers (Rakha et al., 2008). Shao et 
al., (2012) demonstrated that basal-like breast cancers have greater levels of Acheron 
mRNA, and that xenographed human tumors that ectopically expressed Acheron had 
higher rates of proliferation and angiogenesis suggesting that Acheron enhanced tumor 
growth.  
The data in this study suggests that Acheron may be enhancing tumor growth, in 
part, by protecting cells from death via apoptosis. One interpretation of these data is that 
tumors that express Acheron, such as basal-like breast cancers, may be less sensitive to 
chemotherapeutic intervention. Studies have shown that invasive breast cancer tumors 
also have high expression of Laminin-332 (Kim et al., 2012), which plays an important 
role in conferring cell migration and survival by binding to integrins composed of α3β1 
subunits (Zahir et al., 2003). Given that inhibiting Acheron expression results in no 
expression of the Laminin receptor, composed of α7β1 subunits, another interpretation of 
the data is that Acheron promotes tumor growth through regulation of the Laminin 
receptor-perhaps Acheron mediates its effect in breast cancers through the β1 subunit.   
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Future studies need to be conducted in order to further investigate the mechanism 
of Acheron action. Figure 2.1 shows that MDA-MB-231 cells do not natively express 
Acheron, therefore a more appropriate study would be to repeat the cytotoxicity 
experiments from this chapter using a cell line in which endogenous Acheron expression 
has been silenced. Furthermore, this proposed study will have more mechanistic 
relevance if these studies were done in the Manduca GV1 cell line as these arise from 
Manduca embryos and natively express Acheron (Sheel, unpublished).  
Furthermore the Acheron gene used in this study was fused to a HA epitope tag at 
the N-terminus of Acheron via PCR (Shao et al., 2012). Using an anti-HA antibody, co-
immunoprecipitation (co-IP) of Acheron in the MDA-MB-231 cells can be used to 
precipitate Acheron while in a complex with its binding partners. The Acheron 
complexes can then be separated via SDS-PAGE and the resulting proteins can then be 
identified via Mass Spectroscopy. Utilizing this approach, we can identify binding 
partners and possibly elucidate the biochemical pathways that mediate Acheron action.  
The role of Acheron in the ISMs can be further elucidated using the data from this 
chapter. Given that Acheron protects MDA-MB-231 cells from death inducing toxicities, 
the initial predication that Acheron sensitizes the ISMs for death is likely incorrect. In the 
ISMs, one possible role for Acheron is that it serves to protect the cells from endogenous 
death-inducing factors until the actual initiation of death, and then it becomes modified, 
sequestered and/or lost just prior to the actual initiation of PCD.  
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Table 2.1: Stressors used in MDA-MB-231 cytotoxicity assays 
Class Reagent Range Used 
Nutrient Withdrawal Serum Starvation 0 to 48 hours 
Proteosome Inhibition MG132 0.25 µM to 2 µM 
Oxidative Stress H2O2 2 µM to 8 µM 
Heat Shock Increased Temperature 44oC 
Mitochondrial toxin Rotenone 0.25 µM to 5 µM 
DNA Damage Camptothecin 0.25 µM to 5 µM 
Inhibition of cellular 
respiration 
Carbonyl Cyanide-3-
Chlorophenyl Hydrazone 
100 µM to 1000 µM 
 
  
  
 
 
 
 
 
 
 
 
 
 
Figure 2.1: Acheron expression in MDA
MDA-MB-231 cells were transfected with pCMV
Acheron and antibiotic selected. Cells were lysed and expression of Acheron was 
determined in wild type cells, pCMV
transfected cells.   
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Figure 2.2: Effect of Acheron on Nutrient 
Percent viabilities for Acheron expressing or Vector Control MDA
following serum starvation for 6, 24 and 48 hours.
experiment of which each had at least 
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-MB-231 cells 
 Data was pooled from 3 independent 
8 replicates.  Error bars represent ± S.E.M. 
 
 
 
 
  
Figure 2.3: Effect of Acheron on Proteosome Inhibition 
Percent viabilities for Acheron expressing or Vector Control MDA
following treatment with MG132 at 
from 2 independent experiment of which each had at least 8 replicates. Error bars 
represent ± S.E.M.  
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Figure 2.4: Effect of Acheron on Oxidative Stress 
Percent viabilities for Acheron expressing or 
following treatment with H
3 independent experiment of which each had at least 8 replicates. Error bars represent ± 
S.E.M.  
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2O2 at 2 mM, 4 mM, 6 mM and 8 mM. Data was pooled from 
 
 
  
 
Figure 2.5: Effect of Acheron on Heat 
Percent viabilities for Acheron expressing or 
following treatment at 44
experiment of which each had at least 2
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Stress Induced Toxicity. 
vector control MDA-MB-231 cells 
oC for 20 minutes. Data was pooled from 2 independent 
0 replicates. Error bars represent ± S.E.M. 
 
 
 
  
Figure 2.6: Effect of Acheron on Rotenone 
Percent viabilities for Acheron expressing or 
following treatment with Rotenone at 
pooled from 2 independent experiment of which each had at least 8 replicates. Error bars 
represent ± S.E.M.  
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vector control MDA-MB-231 cells 
0.5 µM, 1.0 µM, 2.5 µM and 5.0 µM.
 
 Data was 
  
Figure 2.7: Effect of Acheron on DNA Damage 
Percent viabilities for Acheron expressing or 
following treatment with Camptothecin at 100 nM
was pooled from 2 independent experiment of which each had at least 8 replicates. Error 
bars represent ± S.E.M. 
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Figure 2.8: Effect of Acheron on Inhibition of Cellular 
Toxicity. 
Percent viabilities for Acheron expressing or Vector Control MDA
following treatment with 
µM, 500 µM and 1000 µM.
each had at least 8 replicates. Error bars represent ± S.E.M.
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CHAPTER III 
DEGREDATION OF ACHERON VIA A cGMP MECHANISM 
 
Introduction 
In 1971 Earl Sutherland proposed the Second Messenger hypothesis in which he 
set forth four criteria that need to be fulfilled in order to identify a cyclic nucleotide as a 
second messenger that mediates the action of a given hormone (Sutherland and Robison, 
1966). First, the cell must synthesize the cyclic nucleotide in response to the hormone. 
Second, exogenous addition of the hormone must trigger synthesize of the cyclic 
nucleotide in a dose and time dependent manner. Third, drugs that inhibit 
phosphodiesterase should mimic the action of the hormone. Finally, the fourth criteria of 
this hypothesis was that addition of exogenous cyclic nucleotide should mimic the action 
of the hormone. 
Studies in the silkmoth Antheraea polyphemus have demonstrated that EH 
induces the expression cyclic GMP as a second messenger, and this in turn activates the 
death machinery within the cell (Schwartz et al., 1984). However, the downstream steps 
that couple hormone action to the endogenous “death program” have yet to be identified. 
The study by Schwartz et al., (1984) was novel in that it was one of the first publication 
to fulfill all four of Sutherland’s criteria in order to establish that cGMP is a second 
messenger in any system.  
Western blot analysis has shown that Acheron expression is induced late on day 
17 of pupal-adult development when the ISMs become committed to die late on day 18.  
(“Committed” in this context means that the addition of exogenous 20E will no longer 
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delay the timing of death). The Acheron protein is present in the ISMs throughout all of 
day 18 and then is dramatically and specifically lost from the cells during the few 
minutes before adult eclosion and the activation of the death machinery (Brown and 
Schwartz, unpublished). One interpretation of this expression data is that Acheron 
actually serves as a survival protein that protects the ISMs from the action of the death 
machinery.  When Acheron is then lost, the death program becomes de-repressed and 
serves to kill the cell, making Acheron the proximal trigger for the initiation of death.       
Since EH triggers cGMP, which works via protein kinases that phosphorylate 
specific protein substrates, the Schwartz lab began testing the hypothesis that Acheron 
may be phosphorylated in the ISMs. Western blotting with anti-phospho serine/threonine 
antibody has demonstrated that Acheron is labeled in condemned ISMs (Smith, Brown 
and Schwartz, unpublished), suggesting that it may be subject to regulation in a cGMP 
manner.  
In this chapter I use in vitro cell-free ISMs extracts and a novel non-radioactive 
kinase assay to provide evidence that Acheron is phosphorylated in a cGMP dependent 
manner and that this phosphorylation triggers Acheron degradation.  
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Materials and Methods 
DNA Constructs 
ISMs from day 18 animals were dissected at various times relative to adult 
eclosion, snap frozen on dry ice and stored in liquid nitrogen until used. RNA was 
isolated via RNeasy Mini Kit (Qiagen) and cDNA was synthesized using the SuperScript 
III First-Strand Synthesis System (Invitrogen) per manufacturer’s instructions. The 
following primers were used to amplify the Acheron ORF from the synthesized cDNA:  
For: 5’ TATTGCGTGAATGCGCGCGC 3’ 
Rev: 5’ TCGAACACCGCCACAGCGT 3’ 
The PCR product was cloned into the pCR2.1-TOPO vector via the TOPO TA Cloning 
kit (Invitrogen) to create pCR2.1-TOPO-M44a. pCR2.1.TOPO-M44a was digested with 
EcoRI and the Acheron ORF was subcloned into the EcoRI site of the pMT/V5-HisB 
vector such that Acheron expression was under control of the metallothionine promoter 
(Bunch et al., 1988). The pMT/V5-HisB vector was a generous gift from Dr. Tom 
Maresca.  
Cell Culture 
Drosophila S2 cells were cultured at 28oC in S2 insect media containing 10% 
FBS, penicillin (50 units/mL) and streptomycin (50µg/mL). S2 cells were transfected 
with the pMT/V5-HisB-M44a construct in a 6-well plate using Effectene (Qiagen) 
according to manufacturer’s instructions. 24 hours post transfection, cells were antibiotic 
bulk selected with 25µg/mL Blasticidin (Life Technologies) for 2 weeks. Stable 
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expression of ectopic protein was determined by Western blotting using rabbit an anti-
Acheron antiserum (1:200, Schwartz laboratory).   
Preparation of Intersegmental Muscle Extracts 
 ISMs were isolated from animals at various time on day 18, including 1 hr post-
eclosion (PE).  The tissues were snap frozen on dry ice and stored in liquid nitrogen until 
used for assays.  Strips of ISM tissue from individual animals (two strips of four 
segments each) were pulverized in liquid nitrogen via mortar and pestle, and then 
homogenized using a Type B Dounce Homogenizer at 4oC in phosphate buffered saline 
(137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4 and 2 mM KH2PO4) supplemented with 
cOmplete protease inhibitor (Roche) and PhosStop phosphatase inhibitor (Roche) in 
order to create a broken cell prep (BCP).  
Kinase Assay 
5 µL D18 ISM BCP or S2 extract was combined with 5 µL 1 hour PE extract or 5 
µL D18 ISM BCP and 5 µL of Reaction Mixture (30 mM MgCl2, 1.5 mM DTT, 75 mM 
β-glycerophosphate, pH 7.3, 0.15 mM sodium orthovanadate, 3.75 mM EGTA and 0.3 
mM ATP). 8-Bromo-cGMP, sodium salt (8-bromoguanosine cyclic 3',5'-monophosphate 
sodium salt) (Tocris Bioscience) was added to a final concentration of 10mM. IBMX 
(3,7-Dihydro-1-methyl-3-(2-methylpropyl)-1H-purine-2,6-dione) (Tocris Bioscience) 
was added to final concentration of 10µM. The resulting mixture was incubated at room 
temperature for 20 minutes and then the reaction was stopped by adding an equal volume 
of Sample Buffer (Bio-Rad).  
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Western Blot Analysis 
Samples were boiled for 5 minutes and centrifuged for 1 min at 14,000xg at room 
temperature. Samples were loaded on a 12% SDS-PAGE (Bio-Rad) and were 
electrophoresed for 1 hour at 150 volts at room temperature. Proteins were transferred to 
a PVDF membrane (Millipore). Membrane was blocked in 5% nonfat dry milk in PBST 
and incubated with a rabbit anti-Manduca Acheron antibody (1:200, Schwartz 
Laboratory). HRP labeled goat anti-rabbit antisera (Bio-Rad, 1:3000) and an ECL kit 
(VWR) were used for detection.    
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Results 
ISMs from the day 18 pupal stage of Manduca shows that Acheron, visualized by 
a strong band at 55kDa, is solubilized in the presence of Laemmli buffer as well as in the 
PBS BCP (Figure 3.1). However, in the absence of the phosphodiesterase inhibitor 
IBMX, neither the addition of 8-bromo-cGMP nor addition of ATP triggers a shift in 
molecular weight of Acheron (Figure 3.1). 
Addition of IBMX resulted in an upward shift of the Acheron band on the gel, 
marked by a black arrow. This sample is noted as D18-P. As can be seen in the figure, 
this shift corresponds to an increase in molecular weight compared to both endogenous 
Acheron in the D18 BCP and Acheron ectopically expressed by Drosophila S2 cells 
(Figure 3.2). Figure 3.2 also shows that the higher molecular weight Acheron band 
disappears upon addition of extract from ISMs 1hr PE. However, the modified Acheron 
band remains when the 1hr PE extract is added in the presence of Laemmli buffer (Figure 
3.2). 
Degradation of Acheron was only observed after cGMP and IBMX had been 
added to the day 18 BCP (Figure 3.3). As observed before, addition of the 1 hr PE extract 
resulted in disappearance of the Acheron band seen in the D18-P Acheron sample, 
whereas the Acheron band was still present when the D18-P sample was added to the 1 hr 
PE extract in the presence of Laemmli buffer to arrest any biochemical reactions. 
However addition of D18 extract, without cGMP and IBMX, to the 1 Hr PE extract did 
not result in disappearance of the Acheron band (Figure 3.3).  
I next engineered Drosophila S2 cells to express Manduca Acheron and used that 
as a source of Acheron that would lack the machinery for its eclosion associated 
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degradation.  The stability of the exogenous Acheron appeared to be regulated similarly 
to endogenous ISM Acheron. A band at 55 kDa corresponding to Acheron from S2 
extract could be visualized by Western blotting. Upon addition of the D18 extract along 
with cGMP and IBMX, a thicker band with a slightly higher molecular weight than 
native Acheron was observed (Figure 3.4). However when extract from the 1 hr PE 
sample was added, there was a dramatic reduction in the intensity of this band (Figure 
3.4).  
Our hypothesis is that cGMP dependent kinase phosphorylates Acheron in a 
sequence-specific manner.  As a first step to test this hypothesis, I aligned the Acheron 
protein sequences from Manduca sexta, Drosophila melanogaster, Mus musculus, Danio 
rerio, and Homo sapiens to look for phylogenetically conserved serine residues and 
threonine residue (Figure 3.5).  I observed 7 conserved serine residues at residues 84, 
107, 112, 113, 135, 163 and 284 and one conserved threonine at residue 121 in the 
Manduca sexta Acheron coding sequence. Further motif analysis revealed that the Ser 
163 residue was a potential PKG binding site (Figure 3.5).  
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Discussion 
Given that death of the ISMs is dependent on cGMP as a second messenger, the 
purpose of this study was to test the hypothesis that Acheron degradation is mediated by 
a cGMP-dependent mechanism. In order to test this hypothesis, ISMs were isolated from 
animals at two developmental stages: pre-eclosion day 18and 1 hr PE.  The pre-eclosion 
ISMs contain endogenous Acheron which is missing an hour later.  ISMs were 
homogenized in PBS buffer to create a broken bell preparation (BCP) that should contain 
both Acheron and the enzymatic machinery that modifies the protein.  
As seen in Figure 3.1, there is no shift in molecular weight of Acheron upon the 
addition of either cGMP or ATP in the absence of the phosphodiesterase inhibitor IBMX. 
However upon addition of both IBMX and cGMP, there is an increase in molecular 
weight of Acheron (Figure 3.2). Based on the pattern of the shift, and separate studies 
that demonstrate the presence of phosphor-ser/thr (Smith, Brown and Schwartz, 
unpublished) this shift in molecular weight is presumed to represent a phosphorylation 
event. The fact that the presumptive phosphorylation was dependent on the addition of 
the phosphodiesterase provides further support for the fact that this is likely a cGMP 
mediated process.  
Furthermore, the presumptive phosphorylated Acheron is degraded upon addition 
of the 1 hr PE extract (Figure 3.2). This indicates that the enzymes and proteases required 
to degrade Acheron are present and active in the 1 hr PE extract but not in the D18 
extract.  These data are consistent with previous Western data demonstrating that 
Acheron is present on day 18 but the degraded just prior to adult eclosion and absent 
post-eclosion. 
 44 
 
Phosphorylation of Acheron appears to be required for its degradation (Figure 
3.3). Figure 3.3 shows that when D18 extract, which contains native Acheron, is mixed 
with 1 hr PE ISM extract, Acheron protein is retained.  However, if the same experiment 
is performed in the presence of the phosphodiesterase inhibitor IBMX plus cGMP, then 
Acheron is degraded.  These data support the hypothesis that Acheron phosphorylation is 
required for degradation by enzymes present in the 1 hr PE extract. Finally, exogenously 
synthesized Acheron can also be phosphorylated using the kinases and enzymes present 
in the D18 extract and then degraded after phosphorylation by the 1 hr PE extract (Figure 
3.4).  
One interesting point to emphasize, is that these assays were conducted in the 
presence of Roche’s cOmplete protease inhibitor. Therefore, the degradation of Acheron 
was facilitated by an enzyme or protease that was insensitive to this broad series of 
inhibitors.  In theory, this means that the eclosion associated degradation of Acheron is 
not mediated by the serine proteases trypsin and chymotrypsin, the cysteine protease 
papain, and the metallo-protease thermolysin (Roche). Therefore the “Acheronase” 
pathway utilizes different enzymatic machinery or the protease inhibitors present in this 
cocktail are not very active against the endogenous Manduca proteases used to degrade 
Acheron.  
Given that phosphorylation occurs on serine, threonine and tyrosine residues, in 
order to further validate that Acheron can be phosphorylated, I aligned the Acheron 
sequences from Manduca sexta, Drosophila melanogaster, Mus musculus, Danio rerio, 
and Homo sapiens. The alignment revealed that there are seven evolutionary conserved 
serine residues and one evolutionary conserved threonine residue in the full length 
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Manduca sequence (Figure 3.6). Given that cGMP mediates its effects through Protein 
Kinase G (PKG), analysis of kinase binding motifs of these conserved phosphorylation 
residues, revealed Ser 163 as a possible PKG binding site (Figure 3.6). Taken together, 
the data in this chapter suggests that the dramatic disappearance of Acheron on Day 18 of 
development is due to phosphorylation via a cGMP mediated mechanism, possibly on Ser 
163.      
To further emphasize that this shift corresponds to phosphorylation and not 
acetylation, methylation or another post translational modification, these kinase assays 
need to be repeated using purified Acheron, purified PKG and radioactive 32P. Further 
studies can also be conducted using the above mentioned kinase assays on Acheron 
versions in which the presumed serine residue is mutated to a phospho-null variant, such 
as alanine (Pearlman et al., 2011), or to a phospho-mimic residue such as glutamate or 
aspartate (Pearlman et al., 2011) in order to determine if Acheron can be degraded.      
In Chapter II, I provided evidence that Acheron could possibly function by 
protecting cells. Given the dramatic disappearance of Acheron immediately preceding 
ISM death one possible explanation is that Acheron is protecting the ISMs from death. 
Taken together with the fact that ISM death in Manduca occurs via a cGMP-dependent 
mechanism, the evidence from this chapter suggests that cGMP is responsible for 
triggering the phosphorylation and subsequent degradation of Acheron by Acheron 
specific degradation enzymes present 1 Hr post eclosion.  
Moreover, the data presented here are consistent with the hypothesis that loss of 
Acheron triggers ISM death. A proposed model for the eclosion hormone dependent 
degredation of Acheron and subsequent death of the ISMs is depicted in Figure 3.6. This 
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hypothesis is being tested directly using Acheron RNAi in Drosophila (Johnson, Sheel, 
Markstein and Schwartz, unpublished).  Additional studies are focused on performing co-
immunoprecipitation of Acheron from day 18 ISMs to identify presumptive Acheron 
binding partners.  This might help delineate the mechanism by which Acheron may 
inhibit PCD.  
  
  
  
Figure 3.1: Acheron modification in the absence of the phosphodiesterase inhibitor 
IBMX 
Analysis of Acheron in expression in 
blotting. The first lane (D18
buffer. The second lane (D18
lane (D18+cGMP) contains
prep and exogenous cGMP
contains the products of the kinase reaction with 
cGMP and ATP in the absence of IBMX. 
by a black arrow.    
47 
D18 ISMs with anti-Manduca Acheron via 
-Laemmli) contains lysate from D18 extracted in Laemmli 
-BCP) contains the D18 PBS broken cell prep
 the products of the kinase reaction with D18 
 in the absence of IBMX. The fourth lane (D18+ATP) 
D18 PBS broken cell prep,
The bands corresponding to Acheron is denot
 
 
Western 
. The third 
PBS broken cell 
 exogenous 
ed 
  
Figure 3.2: Endogenous Acheron 
Analysis of Acheron after the kinase assay using
Acheron via Western blotting
cell prep. The second lane (S2 Ext) contains
engineered to express ectopic 
products of the kinase assay using 
and IBMX. The fourth lane (1Hr + D18
BCP from ISMs staged at 
D18-P in Laemmli) contains the products of the reaction when BCP from ISMs staged at 
1hr PE is added to the D18
the modified Acheron is denoted by a black arrow. 
 
48 
Modification and Degradation 
 D18 ISMs detected with anti
. The first lane (D18 BCP) contains the D18 PBS broken 
 the extract from Drosophila 
Manduca Acheron. The third lane (D18-P) contains
the D18 PBS broken cell prep with exogenous cGMP
-P) contains the products of the reaction when 
1hr PE is added to the D18-P sample. The fifth lane (1Hr + 
-P sample in the presence of Laemmli buffer. 
   
 
 
-Manduca 
S2 cells 
 the 
 
The presence of 
  
Figure 3.3: Presumptive 
degradation 
Analysis of Acheron after the 
Acheron via Western blotti
assay using the D18 PBS broken cell prep with exogenous cGMP and IBMX. The second
lane (1Hr + D18-P) contains t
1hr PE is added to the D18
arrow. The third lane (1Hr + D18
when BCP from ISMs staged at 
Laemmli buffer. The fourth 
reaction when BCP from ISMs staged at 
presence of Laemmli buffer. The fifth
reaction when BCP from ISMs staged at 
 
49 
Phosphorylation of native Acheron is required for 
kinase assay using D18 ISMs detected with anti
ng. The first lane (D18-P) contains the products of the kinase 
he products of the reaction when BCP from ISMs staged at 
-P sample. The absence of Acheron protein is marked by an 
-P in Laemmli) contains the products of the reaction 
1hr PE is added to the D18-P sample in the presen
lane (1hr + D18 in Laemmli) contains the products of the 
1hr PE is added to the BCP from D18 in the 
 lane (1hr + D18) contains the products of the 
1hr PE is added to the BCP from D18. 
 
 
 
 
 
 
-Manduca 
 
ce of 
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